| Tretinoin | Approved Investigational Nutraceutical | DACT1 | 51339 |
upregulated | Tretinoin results in increased expression of DACT1 mRNA | 14q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DACT3 | 147906 |
upregulated | Tretinoin results in increased expression of DACT3 mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | DAG1 | 1605 |
downregulated | Tretinoin results in decreased expression of DAG1 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | DAND5 | 199699 |
downregulated | Tretinoin results in decreased expression of DAND5 mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | DAPK1 | 1612 |
downregulated | Tretinoin results in decreased expression of DAPK1 mRNA | 9q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DAPK1 | 1612 |
upregulated | Tretinoin results in increased expression of DAPK1 mRNA | 9q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DAPK2 | 23604 |
upregulated | Tretinoin results in increased expression of DAPK2 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | DAZL | 1618 |
downregulated | Tretinoin results in decreased expression of DAZL mRNA | 3p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DBH | 1621 |
downregulated | Tretinoin results in decreased expression of DBH mRNA | 9q34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DBNDD1 | 79007 |
downregulated | Tretinoin results in decreased expression of DBNDD1 mRNA | 16q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DBNDD2 | 55861 |
downregulated | Tretinoin results in decreased expression of DBNDD2 mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | DCAF13 | 25879 |
downregulated | Tretinoin results in decreased expression of DCAF13 mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DCBLD1 | 285761 |
upregulated | Tretinoin results in increased expression of DCBLD1 mRNA | 6q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DCDC2 | 51473 |
upregulated | Tretinoin results in increased expression of DCDC2 mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DCK | 1633 |
downregulated | Tretinoin results in decreased expression of DCK mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DCLK2 | 166614 |
upregulated | Tretinoin results in increased expression of DCLK2 mRNA | 4q31.23-q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DCN | 1634 |
upregulated | Tretinoin results in increased expression of DCN mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DCT | 1638 |
downregulated | Tretinoin results in decreased expression of DCT mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DCX | 1641 |
upregulated | Tretinoin results in increased expression of DCX mRNA | Xq23 | |
| Tretinoin | Approved Investigational Nutraceutical | DCXR | 51181 |
upregulated | Tretinoin results in increased expression of DCXR mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DDAH1 | 23576 |
downregulated | Tretinoin results in decreased expression of DDAH1 mRNA | 1p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DDAH2 | 23564 |
downregulated | Tretinoin results in decreased expression of DDAH2 mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DDC | 1644 |
downregulated | Tretinoin results in decreased expression of DDC mRNA | 7p12.2-p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDC | 1644 |
upregulated | Tretinoin results in increased expression of DDC mRNA | 7p12.2-p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDIT3 | 1649 |
upregulated | Tretinoin results in increased expression of DDIT3 mRNA | 12q13.3 | |